Wenqiang Liu
- Molecular Biology top 5%
- Pluripotent Stem Cells Research 19
- CRISPR and Genetic Engineering 17
- Epigenetics and DNA Methylation 17
- Renal and related cancers 15
- Aging top 10%
- Cancer Research top 5%
-
- Reproductive Biology and Fertility 14
- Reproductive Medicine top 5%
-
- Cardiovascular Function and Risk Factors 11
-
- Renal cell carcinoma treatment 9
-
- Cardiac Structural Anomalies and Repair 9
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wenqiang Liu
123 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 2.2k
- Aging 38
- Cancer Research 310
- Public Health, Environmental and Occupational Health 377
- Reproductive Medicine 103
Countries citing papers authored by Wenqiang Liu
This map shows the geographic impact of Wenqiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqiang Liu more than expected).
Fields of papers citing papers by Wenqiang Liu
This network shows the impact of papers produced by Wenqiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqiang Liu. The network helps show where Wenqiang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenqiang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 8 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 11 | |
| 18 | 2019 | 22 | |
| 19 | 2018 | 18 | |
| 20 | 2017 | 18 |
About Wenqiang Liu
Wenqiang Liu is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine, having authored 135 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (19 papers), CRISPR and Genetic Engineering (17 papers), Epigenetics and DNA Methylation (17 papers), Renal and related cancers (15 papers), Reproductive Biology and Fertility (14 papers), Cardiovascular Function and Risk Factors (11 papers), Renal cell carcinoma treatment (9 papers) and Cardiac Structural Anomalies and Repair (9 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Aging (38 citations) and Cancer Research (310 citations). Wenqiang Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shaorong Gao, Xiaochen Kou, Yawei Gao, Yanhong Zhao, Jiayu Chen, Yong Zhang, Chenfei Wang, Xiaoyu Liu, Chong Li and Hong Wang. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.